Structural insights into catalytical capability for CPT11 hydrolysis and substrate specificity of a novel marine microbial carboxylesterase, E93

CPT11 (Irinotecan; 7-ethyl-10-[4-(1-piperidino)-1-piperidino] carbonyloxycamptothecin) is an important camptothecin-based broad-spectrum anticancer prodrug. The activation of its warhead, SN38 (7-ethyl-10-hydroxycamptothecin), requires hydrolysis by carboxylesterases. NPC (7-ethyl-10-[4-(1-piperidin...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in microbiology Vol. 13; p. 1081094
Main Authors Li, Yang, Rong, Zhen, Li, Zhengyang, Cui, Henglin, Li, Jixi, Xu, Xue-Wei
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 11.01.2023
Subjects
Online AccessGet full text
ISSN1664-302X
1664-302X
DOI10.3389/fmicb.2022.1081094

Cover

Loading…
Abstract CPT11 (Irinotecan; 7-ethyl-10-[4-(1-piperidino)-1-piperidino] carbonyloxycamptothecin) is an important camptothecin-based broad-spectrum anticancer prodrug. The activation of its warhead, SN38 (7-ethyl-10-hydroxycamptothecin), requires hydrolysis by carboxylesterases. NPC (7-ethyl-10-[4-(1-piperidino)-1-amino] carbonyloxycamptothecin) is a metabolic derivative of CPT11 and is difficult to be hydrolyzed by human carboxylesterase. Microbial carboxylesterase with capability on both CPT11 and NPC hydrolysis is rarely reported. A marine microbial carboxylesterase, E93, was identified to hydrolyze both substrates in this study. This enzyme was an appropriate subject for uncovering the catalytic mechanism of carboxylesterases to CPT11 and NPC hydrolysis. X-ray diffraction method was applied to obtain high-resolution structure of E93. Molecular docking was adopted to analyze the interaction of E93 with -NP ( -nitrophenyl), CPT11, and NPC substrates. Mutagenesis and enzymatic assay were adopted to verify the binding pattern of substrates. Three core regions (Region A, B, and C) of the catalytic pocket were identified and their functions on substrates specificity were validated mutagenesis assays. The Region A was involved in the binding with the alcohol group of all tested substrates. The size and hydrophobicity of the region determined the binding affinity. The Region B accommodated the acyl group of -NP and CPT11 substrates. The polarity of this region determined the catalytic preference to both substrates. The Region C specifically accommodated the acyl group of NPC. The interaction from the acidic residue, E428, contributed to the binding of E93 with NPC. The study analyzed both unique and conserved structures of the pocket in E93, for the first time demonstrating the discrepancy of substrate-enzyme interaction between CPT11 and NPC. It also expanded the knowledge about the substrate specificity and potential application of microbial Family VII carboxylesterases.
AbstractList CPT11 (Irinotecan; 7-ethyl-10-[4-(1-piperidino)-1-piperidino] carbonyloxycamptothecin) is an important camptothecin-based broad-spectrum anticancer prodrug. The activation of its warhead, SN38 (7-ethyl-10-hydroxycamptothecin), requires hydrolysis by carboxylesterases. NPC (7-ethyl-10-[4-(1-piperidino)-1-amino] carbonyloxycamptothecin) is a metabolic derivative of CPT11 and is difficult to be hydrolyzed by human carboxylesterase. Microbial carboxylesterase with capability on both CPT11 and NPC hydrolysis is rarely reported. A marine microbial carboxylesterase, E93, was identified to hydrolyze both substrates in this study. This enzyme was an appropriate subject for uncovering the catalytic mechanism of carboxylesterases to CPT11 and NPC hydrolysis. X-ray diffraction method was applied to obtain high-resolution structure of E93. Molecular docking was adopted to analyze the interaction of E93 with -NP ( -nitrophenyl), CPT11, and NPC substrates. Mutagenesis and enzymatic assay were adopted to verify the binding pattern of substrates. Three core regions (Region A, B, and C) of the catalytic pocket were identified and their functions on substrates specificity were validated mutagenesis assays. The Region A was involved in the binding with the alcohol group of all tested substrates. The size and hydrophobicity of the region determined the binding affinity. The Region B accommodated the acyl group of -NP and CPT11 substrates. The polarity of this region determined the catalytic preference to both substrates. The Region C specifically accommodated the acyl group of NPC. The interaction from the acidic residue, E428, contributed to the binding of E93 with NPC. The study analyzed both unique and conserved structures of the pocket in E93, for the first time demonstrating the discrepancy of substrate-enzyme interaction between CPT11 and NPC. It also expanded the knowledge about the substrate specificity and potential application of microbial Family VII carboxylesterases.
IntroductionCPT11 (Irinotecan; 7-ethyl-10-[4-(1-piperidino)-1-piperidino] carbonyloxycamptothecin) is an important camptothecin-based broad-spectrum anticancer prodrug. The activation of its warhead, SN38 (7-ethyl-10-hydroxycamptothecin), requires hydrolysis by carboxylesterases. NPC (7-ethyl-10-[4-(1-piperidino)-1-amino] carbonyloxycamptothecin) is a metabolic derivative of CPT11 and is difficult to be hydrolyzed by human carboxylesterase. Microbial carboxylesterase with capability on both CPT11 and NPC hydrolysis is rarely reported. A marine microbial carboxylesterase, E93, was identified to hydrolyze both substrates in this study. This enzyme was an appropriate subject for uncovering the catalytic mechanism of carboxylesterases to CPT11 and NPC hydrolysis.MethodsX-ray diffraction method was applied to obtain high-resolution structure of E93. Molecular docking was adopted to analyze the interaction of E93 with p-NP (p-nitrophenyl), CPT11, and NPC substrates. Mutagenesis and enzymatic assay were adopted to verify the binding pattern of substrates.ResultsThree core regions (Region A, B, and C) of the catalytic pocket were identified and their functions on substrates specificity were validated via mutagenesis assays. The Region A was involved in the binding with the alcohol group of all tested substrates. The size and hydrophobicity of the region determined the binding affinity. The Region B accommodated the acyl group of p-NP and CPT11 substrates. The polarity of this region determined the catalytic preference to both substrates. The Region C specifically accommodated the acyl group of NPC. The interaction from the acidic residue, E428, contributed to the binding of E93 with NPC.DiscussionThe study analyzed both unique and conserved structures of the pocket in E93, for the first time demonstrating the discrepancy of substrate-enzyme interaction between CPT11 and NPC. It also expanded the knowledge about the substrate specificity and potential application of microbial Family VII carboxylesterases.
CPT11 (Irinotecan; 7-ethyl-10-[4-(1-piperidino)-1-piperidino] carbonyloxycamptothecin) is an important camptothecin-based broad-spectrum anticancer prodrug. The activation of its warhead, SN38 (7-ethyl-10-hydroxycamptothecin), requires hydrolysis by carboxylesterases. NPC (7-ethyl-10-[4-(1-piperidino)-1-amino] carbonyloxycamptothecin) is a metabolic derivative of CPT11 and is difficult to be hydrolyzed by human carboxylesterase. Microbial carboxylesterase with capability on both CPT11 and NPC hydrolysis is rarely reported. A marine microbial carboxylesterase, E93, was identified to hydrolyze both substrates in this study. This enzyme was an appropriate subject for uncovering the catalytic mechanism of carboxylesterases to CPT11 and NPC hydrolysis.IntroductionCPT11 (Irinotecan; 7-ethyl-10-[4-(1-piperidino)-1-piperidino] carbonyloxycamptothecin) is an important camptothecin-based broad-spectrum anticancer prodrug. The activation of its warhead, SN38 (7-ethyl-10-hydroxycamptothecin), requires hydrolysis by carboxylesterases. NPC (7-ethyl-10-[4-(1-piperidino)-1-amino] carbonyloxycamptothecin) is a metabolic derivative of CPT11 and is difficult to be hydrolyzed by human carboxylesterase. Microbial carboxylesterase with capability on both CPT11 and NPC hydrolysis is rarely reported. A marine microbial carboxylesterase, E93, was identified to hydrolyze both substrates in this study. This enzyme was an appropriate subject for uncovering the catalytic mechanism of carboxylesterases to CPT11 and NPC hydrolysis.X-ray diffraction method was applied to obtain high-resolution structure of E93. Molecular docking was adopted to analyze the interaction of E93 with p-NP (p-nitrophenyl), CPT11, and NPC substrates. Mutagenesis and enzymatic assay were adopted to verify the binding pattern of substrates.MethodsX-ray diffraction method was applied to obtain high-resolution structure of E93. Molecular docking was adopted to analyze the interaction of E93 with p-NP (p-nitrophenyl), CPT11, and NPC substrates. Mutagenesis and enzymatic assay were adopted to verify the binding pattern of substrates.Three core regions (Region A, B, and C) of the catalytic pocket were identified and their functions on substrates specificity were validated via mutagenesis assays. The Region A was involved in the binding with the alcohol group of all tested substrates. The size and hydrophobicity of the region determined the binding affinity. The Region B accommodated the acyl group of p-NP and CPT11 substrates. The polarity of this region determined the catalytic preference to both substrates. The Region C specifically accommodated the acyl group of NPC. The interaction from the acidic residue, E428, contributed to the binding of E93 with NPC.ResultsThree core regions (Region A, B, and C) of the catalytic pocket were identified and their functions on substrates specificity were validated via mutagenesis assays. The Region A was involved in the binding with the alcohol group of all tested substrates. The size and hydrophobicity of the region determined the binding affinity. The Region B accommodated the acyl group of p-NP and CPT11 substrates. The polarity of this region determined the catalytic preference to both substrates. The Region C specifically accommodated the acyl group of NPC. The interaction from the acidic residue, E428, contributed to the binding of E93 with NPC.The study analyzed both unique and conserved structures of the pocket in E93, for the first time demonstrating the discrepancy of substrate-enzyme interaction between CPT11 and NPC. It also expanded the knowledge about the substrate specificity and potential application of microbial Family VII carboxylesterases.DiscussionThe study analyzed both unique and conserved structures of the pocket in E93, for the first time demonstrating the discrepancy of substrate-enzyme interaction between CPT11 and NPC. It also expanded the knowledge about the substrate specificity and potential application of microbial Family VII carboxylesterases.
Author Rong, Zhen
Li, Jixi
Xu, Xue-Wei
Li, Yang
Cui, Henglin
Li, Zhengyang
AuthorAffiliation 1 School of Oceanography, Zhejiang University , Zhoushan , China
4 School of Food and Biological Engineering, Jiangsu University , Zhenjiang , China
3 State Key Laboratory of Genetic Engineering, School of Life Sciences, Shanghai Engineering Research Center of Industrial Microorganisms, Fudan University , Shanghai , China
2 Key Laboratory of Marine Ecosystem Dynamics, Ministry of Natural Resources and Second Institute of Oceanography, Ministry of Natural Resources , Hangzhou , China
AuthorAffiliation_xml – name: 1 School of Oceanography, Zhejiang University , Zhoushan , China
– name: 3 State Key Laboratory of Genetic Engineering, School of Life Sciences, Shanghai Engineering Research Center of Industrial Microorganisms, Fudan University , Shanghai , China
– name: 2 Key Laboratory of Marine Ecosystem Dynamics, Ministry of Natural Resources and Second Institute of Oceanography, Ministry of Natural Resources , Hangzhou , China
– name: 4 School of Food and Biological Engineering, Jiangsu University , Zhenjiang , China
Author_xml – sequence: 1
  givenname: Yang
  surname: Li
  fullname: Li, Yang
– sequence: 2
  givenname: Zhen
  surname: Rong
  fullname: Rong, Zhen
– sequence: 3
  givenname: Zhengyang
  surname: Li
  fullname: Li, Zhengyang
– sequence: 4
  givenname: Henglin
  surname: Cui
  fullname: Cui, Henglin
– sequence: 5
  givenname: Jixi
  surname: Li
  fullname: Li, Jixi
– sequence: 6
  givenname: Xue-Wei
  surname: Xu
  fullname: Xu, Xue-Wei
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36756200$$D View this record in MEDLINE/PubMed
BookMark eNp9Uk1vEzEQXaEiWkr_AAfkIwcS_LXe9QUJRQUqVQKJHLhZY683ceWsg-2t2H_BT8abhKrlgA_2yPPmzfP4vazOhjDYqnpN8JKxVr7vd87oJcWULgluCZb8WXVBhOALhumPs0fxeXWV0h0ui2Na9hfVORNNLUp8Uf3-nuNo8hjBIzckt9nmVIIckIEMfsrOlIyBPWjnXZ5QHyJafVsTgrZTF4OfkksIhg6lUaccIVuU9ta43pkZHnoEaAj31qMdRDdYVHTHoN2BNerwa_I2ZRsh2XfoWrJX1fMefLJXp_OyWn-6Xq--LG6_fr5ZfbxdGC7avOAd7jEnvK-B8hr3XDYYNBOkpqQFC4LVrIWuMVYIgXXdCSZbKjW0rbYdYZfVzZG2C3Cn9tEVdZMK4NThIsSNglge763ilDZYGKM14xxjKo1oTE1ZGTm13HSF68ORaz_qne2MHcoc_BPSp5nBbdUm3CspMWnkLObtiSCGn2MZh9q5ZKz3MNgwJkWbhreSy5YV6JvHvR6a_P3RAqBHQJlyStH2DxCC1ewcdXCOmp2jTs4pRe0_ReXzILsw63X-f6V_AF2Ly_I
CitedBy_id crossref_primary_10_1016_j_ijbiomac_2024_137899
crossref_primary_10_1111_1751_7915_14479
Cites_doi 10.1093/nar/gkq366
10.1007/s12032-019-1309-6
10.1016/j.cbi.2006.07.001
10.1016/S1359-6446(05)03383-0
10.3390/cancers11101581
10.1016/j.bcp.2005.11.020
10.1093/nar/gks1154
10.1107/S0907444904019158
10.1124/dmd.32.5.505
10.1107/S0907444909052925
10.1186/1752-153X-2-18
10.1016/j.bcp.2007.06.022
10.1517/17425247.2015.1070142
10.1002/jbt.20178
10.1124/jpet.112.201640
10.1042/0264-6021:3430177
10.2174/138955710792007196
10.1021/bi035586r
10.3390/molecules13020412
10.1038/nrc1977
10.1002/cpz1.292
10.1038/nrd2468
10.7314/apjcp
10.1099/ijs.0.057257-0
10.21873/invivo.11856
10.1107/S2059798317017557
10.1093/molbev/msw054
10.1016/j.pestbp.2020.104704
10.1021/cb800065s
10.1124/dmd.31.1.21
10.1016/j.jconrel.2013.05.005
10.1093/nar/gkq822
ContentType Journal Article
Copyright Copyright © 2023 Li, Rong, Li, Cui, Li and Xu.
Copyright © 2023 Li, Rong, Li, Cui, Li and Xu. 2023 Li, Rong, Li, Cui, Li and Xu
Copyright_xml – notice: Copyright © 2023 Li, Rong, Li, Cui, Li and Xu.
– notice: Copyright © 2023 Li, Rong, Li, Cui, Li and Xu. 2023 Li, Rong, Li, Cui, Li and Xu
DBID AAYXX
CITATION
NPM
7X8
5PM
DOA
DOI 10.3389/fmicb.2022.1081094
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList PubMed

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1664-302X
ExternalDocumentID oai_doaj_org_article_422706ccbb3440029c67c5230942e4cd
PMC9901791
36756200
10_3389_fmicb_2022_1081094
Genre Journal Article
GroupedDBID 53G
5VS
9T4
AAFWJ
AAKDD
AAYXX
ACGFO
ACGFS
ACXDI
ADBBV
ADRAZ
AENEX
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
CITATION
DIK
ECGQY
GROUPED_DOAJ
GX1
HYE
KQ8
M48
M~E
O5R
O5S
OK1
PGMZT
RNS
RPM
IAO
IEA
IHR
IPNFZ
NPM
RIG
7X8
5PM
ID FETCH-LOGICAL-c468t-4d0f0414f5a2450f4970ab3615218aea63538ad7ce6660b5d639829ba88bed13
IEDL.DBID M48
ISSN 1664-302X
IngestDate Wed Aug 27 01:31:53 EDT 2025
Thu Aug 21 18:38:55 EDT 2025
Fri Jul 11 07:02:56 EDT 2025
Thu Jan 02 22:54:59 EST 2025
Thu Apr 24 22:52:32 EDT 2025
Tue Jul 01 00:57:59 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords prodrug
crystal structure
enzyme catalysis
marine bacterial carboxylesterase
p-nitrophenyl
substrate specificity
Language English
License Copyright © 2023 Li, Rong, Li, Cui, Li and Xu.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c468t-4d0f0414f5a2450f4970ab3615218aea63538ad7ce6660b5d639829ba88bed13
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Reviewed by: Dirk Tischler, Ruhr University Bochum, Germany; Hirokazu Suzuki, Tottori University, Japan
This article was submitted to Microbiotechnology, a section of the journal Frontiers in Microbiology
Edited by: Jixun Zhan, Utah State University, United States
OpenAccessLink https://doaj.org/article/422706ccbb3440029c67c5230942e4cd
PMID 36756200
PQID 2774894983
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_422706ccbb3440029c67c5230942e4cd
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9901791
proquest_miscellaneous_2774894983
pubmed_primary_36756200
crossref_primary_10_3389_fmicb_2022_1081094
crossref_citationtrail_10_3389_fmicb_2022_1081094
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2023-01-11
PublicationDateYYYYMMDD 2023-01-11
PublicationDate_xml – month: 01
  year: 2023
  text: 2023-01-11
  day: 11
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
PublicationTitle Frontiers in microbiology
PublicationTitleAlternate Front Microbiol
PublicationYear 2023
Publisher Frontiers Media S.A
Publisher_xml – name: Frontiers Media S.A
References Hosokawa (ref12) 2008; 13
Adams (ref1) 2010; 66
Barber (ref4) 2021; 1
Gentry (ref9) 2011; 39
Fukuchi (ref8) 2020; 34
Xie (ref40) 2003; 31
Reita (ref26) 2019; 11
Wang (ref38) 2020; 170
Sanghani (ref29) 2004; 32
Palakurthi (ref21) 2015; 12
Jiang (ref16) 2008; 2
Stubdal (ref35) 2003; 63
Wierdl (ref39) 2004; 43
Zhang (ref41) 2015; 16
Lenfant (ref20) 2013; 41
Holm (ref11) 2010; 38
Ross (ref27) 2006; 71
Satoh (ref31) 2006; 162
Zhu (ref42) 2013; 344
Pommier (ref23) 2006; 6
Hough (ref13) 2018; 74
Jewell (ref15) 2007; 74
Santos (ref30) 2000; 6
Tossey (ref37) 2019; 36
Seo (ref33) 2010; 60
Emsley (ref7) 2004; 60
Lavis (ref18) 2008; 3
Schellmann (ref32) 2010; 10
Lehouritis (ref19) 2013; 170
Rautio (ref24) 2008; 7
Redinbo (ref25) 2005; 10
Arpigny (ref2) 1999; 343
Kumar (ref17) 2016; 33
Ross (ref28) 2007; 21
References_xml – volume: 38
  start-page: W545
  year: 2010
  ident: ref11
  article-title: Dali server: conservation mapping in 3D
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkq366
– volume: 36
  start-page: 87
  year: 2019
  ident: ref37
  article-title: Comparison of conventional versus liposomal irinotecan in combination with fluorouracil for advanced pancreatic cancer: a single-institution experience
  publication-title: Med. Oncol.
  doi: 10.1007/s12032-019-1309-6
– volume: 162
  start-page: 195
  year: 2006
  ident: ref31
  article-title: Structure, function and regulation of carboxylesterases
  publication-title: Chem. Biol. Interact.
  doi: 10.1016/j.cbi.2006.07.001
– volume: 10
  start-page: 313
  year: 2005
  ident: ref25
  article-title: Mammalian carboxylesterases: from drug targets to protein therapeutics
  publication-title: Drug Discov. Today
  doi: 10.1016/S1359-6446(05)03383-0
– volume: 11
  start-page: 1581
  year: 2019
  ident: ref26
  article-title: Synergistic anti-tumor effect of mTOR inhibitors with irinotecan on colon cancer cells
  publication-title: Cancers
  doi: 10.3390/cancers11101581
– volume: 71
  start-page: 657
  year: 2006
  ident: ref27
  article-title: Hydrolytic metabolism of pyrethroids by human and other mammalian carboxylesterases
  publication-title: Biochem. Pharmacol.
  doi: 10.1016/j.bcp.2005.11.020
– volume: 41
  start-page: D423
  year: 2013
  ident: ref20
  article-title: ESTHER, the database of the alpha/beta-hydrolase fold superfamily of proteins: tools to explore diversity of functions
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gks1154
– volume: 60
  start-page: 2126
  year: 2004
  ident: ref7
  article-title: Coot: model-building tools for molecular graphics
  publication-title: Acta Crystallogr. D Biol. Crystallogr.
  doi: 10.1107/S0907444904019158
– volume: 6
  start-page: 2012
  year: 2000
  ident: ref30
  article-title: Metabolism of irinotecan (CPT-11) by CYP3A4 and CYP3A5 in humans
  publication-title: Clin. Cancer Res.
– volume: 32
  start-page: 505
  year: 2004
  ident: ref29
  article-title: Hydrolysis of irinotecan and its oxidative metabolites, 7-ethyl-10-[4-N-(5-aminopentanoic acid)-1-piperidino] carbonyloxycamptothecin and 7-ethyl-10-[4-(1-piperidino)-1-amino]-carbonyloxycamptothecin, by human carboxylesterases CES1A1, CES2, and a newly expressed carboxylesterase isoenzyme, CES3
  publication-title: Drug Metab. Dispos.
  doi: 10.1124/dmd.32.5.505
– volume: 66
  start-page: 213
  year: 2010
  ident: ref1
  article-title: PHENIX: a comprehensive Python-based system for macromolecular structure solution
  publication-title: Acta Crystallogr. D Biol. Crystallogr.
  doi: 10.1107/S0907444909052925
– volume: 2
  start-page: 18
  year: 2008
  ident: ref16
  article-title: DOVIS 2.0: an efficient and easy to use parallel virtual screening tool based on AutoDock 4.0
  publication-title: Chem. Cent. J.
  doi: 10.1186/1752-153X-2-18
– volume: 74
  start-page: 932
  year: 2007
  ident: ref15
  article-title: Inter-individual variability in esterases in human liver
  publication-title: Biochem. Pharmacol.
  doi: 10.1016/j.bcp.2007.06.022
– volume: 12
  start-page: 1911
  year: 2015
  ident: ref21
  article-title: Challenges in SN38 drug delivery: current success and future directions
  publication-title: Expert Opin. Drug Deliv.
  doi: 10.1517/17425247.2015.1070142
– volume: 21
  start-page: 187
  year: 2007
  ident: ref28
  article-title: Human carboxylesterases and their role in xenobiotic and endobiotic metabolism
  publication-title: J. Biochem. Mol. Toxicol.
  doi: 10.1002/jbt.20178
– volume: 344
  start-page: 665
  year: 2013
  ident: ref42
  article-title: Carboxylesterase 1 as a determinant of clopidogrel metabolism and activation
  publication-title: J. Pharmacol. Exp. Ther.
  doi: 10.1124/jpet.112.201640
– volume: 343
  start-page: 177
  year: 1999
  ident: ref2
  article-title: Bacterial lipolytic enzymes: classification and properties
  publication-title: Biochem. J.
  doi: 10.1042/0264-6021:3430177
– volume: 10
  start-page: 887
  year: 2010
  ident: ref32
  article-title: Targeted enzyme prodrug therapies
  publication-title: Mini Rev. Med. Chem.
  doi: 10.2174/138955710792007196
– volume: 43
  start-page: 1874
  year: 2004
  ident: ref39
  article-title: Molecular modeling of CPT-11 metabolism by carboxylesterases (CEs): use of pnbCE as a model
  publication-title: Biochemistry
  doi: 10.1021/bi035586r
– volume: 13
  start-page: 412
  year: 2008
  ident: ref12
  article-title: Structure and catalytic properties of carboxylesterase isozymes involved in metabolic activation of prodrugs
  publication-title: Molecules
  doi: 10.3390/molecules13020412
– volume: 6
  start-page: 789
  year: 2006
  ident: ref23
  article-title: Topoisomerase I inhibitors: camptothecins and beyond
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc1977
– volume: 1
  start-page: e292
  year: 2021
  ident: ref4
  article-title: Software to visualize proteins and perform structural alignments
  publication-title: Curr. Protoc.
  doi: 10.1002/cpz1.292
– volume: 7
  start-page: 255
  year: 2008
  ident: ref24
  article-title: Prodrugs: design and clinical applications
  publication-title: Nat. Rev. Drug Discov.
  doi: 10.1038/nrd2468
– volume: 16
  start-page: 1993
  year: 2015
  ident: ref41
  article-title: Irinotecan as a second-line chemotherapy for small cell lung cancer: a systemic analysis
  publication-title: Asian Pac. J. Cancer Prev.
  doi: 10.7314/apjcp
– volume: 60
  start-page: 307
  year: 2010
  ident: ref33
  article-title: Altererythrobacter marensis sp. nov., isolated from seawater
  publication-title: Int. J. Syst. Evol. Microbiol.
  doi: 10.1099/ijs.0.057257-0
– volume: 34
  start-page: 903
  year: 2020
  ident: ref8
  article-title: Efficacy of irinotecan as third-line chemotherapy for unresectable or recurrent gastric cancer
  publication-title: In Vivo
  doi: 10.21873/invivo.11856
– volume: 74
  start-page: 67
  year: 2018
  ident: ref13
  article-title: From crystal to structure with CCP4
  publication-title: Acta Crystallogr. D Struct. Biol.
  doi: 10.1107/S2059798317017557
– volume: 33
  start-page: 1870
  year: 2016
  ident: ref17
  article-title: MEGA7: molecular evolutionary genetics analysis version 7.0 for bigger datasets
  publication-title: Mol. Biol. Evol.
  doi: 10.1093/molbev/msw054
– volume: 63
  start-page: 6900
  year: 2003
  ident: ref35
  article-title: A prodrug strategy using ONYX-015-based replicating adenoviruses to deliver rabbit carboxylesterase to tumor cells for conversion of CPT-11 to SN-38
  publication-title: Cancer Res.
– volume: 170
  start-page: 104704
  year: 2020
  ident: ref38
  article-title: Characterization of a novel hyper-thermostable and chlorpyrifos-hydrolyzing carboxylesterase EstC: a representative of the new esterase family XIX
  publication-title: Pestic. Biochem. Physiol.
  doi: 10.1016/j.pestbp.2020.104704
– volume: 3
  start-page: 203
  year: 2008
  ident: ref18
  article-title: Ester bonds in prodrugs
  publication-title: ACS Chem. Biol.
  doi: 10.1021/cb800065s
– volume: 31
  start-page: 21
  year: 2003
  ident: ref40
  article-title: Mouse liver and kidney carboxylesterase (M-LK) rapidly hydrolyzes antitumor prodrug irinotecan and the N-terminal three quarter sequence determines substrate selectivity
  publication-title: Drug Metab. Dispos.
  doi: 10.1124/dmd.31.1.21
– volume: 170
  start-page: 120
  year: 2013
  ident: ref19
  article-title: Bacterial-directed enzyme prodrug therapy
  publication-title: J. Control. Release
  doi: 10.1016/j.jconrel.2013.05.005
– volume: 39
  start-page: 1014
  year: 2011
  ident: ref9
  article-title: The geometry of DNA supercoils modulates the DNA cleavage activity of human topoisomerase I
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkq822
SSID ssj0000402000
Score 2.3416739
Snippet CPT11 (Irinotecan; 7-ethyl-10-[4-(1-piperidino)-1-piperidino] carbonyloxycamptothecin) is an important camptothecin-based broad-spectrum anticancer prodrug....
IntroductionCPT11 (Irinotecan; 7-ethyl-10-[4-(1-piperidino)-1-piperidino] carbonyloxycamptothecin) is an important camptothecin-based broad-spectrum anticancer...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 1081094
SubjectTerms crystal structure
enzyme catalysis
marine bacterial carboxylesterase
Microbiology
p-nitrophenyl
prodrug
substrate specificity
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3di9QwEA9yIPgifts7lQi-aTFJp03yqMcdhw8iuMK9lXyVW9hrj9tVrv-Ff7IzaW_ZFdEX30qbtiEzycwvmfkNY298AJtsCmV0nS0hNVAaNOxlHaVJNqoYuhxt8bk5-wafzuvznVJfFBM20QNPA_celNKiCcH7CoDOkEKjA21lWlAJQqTVF23eDpjKazDBIiGmLBlEYRbFtAwe8aBSFFYnhYU9S5QJ-__kZf4eLLljfU4fsPuz28g_TN19yO6k_hG7OxWSHB-zn18zDSxRaPBlvybAvcaLzcDz9syYN6zx-mpi5R45uqr8-MtCSn4xxush85Jw10e-xoUkE9ZyysGkOCJqPnTc8X74kVb80lG-IL9cZgan_NVrP9yMq0y5gDbxHT-x1RO2OD1ZHJ-Vc62FMkBjNiVE0QmQ0NVOQS06sFo4XzVk3o1LDv2SyrioQ0K8I3wd0bMxynpnjE9RVk_ZQT_06Tnj0ngHIWlKsgXhpEum7lKlvaySUikUTN4OextmHnIqh7FqEY-QqNosqpZE1c6iKtjb7TtXEwvHX1t_JGluWxKDdr6BetXOetX-S68K9vpWF1qccXSM4vo0fF-3ShNjD1hTFezZpBvbX1WIvxrUvILpPa3Z68v-k355kVm96YBSW3n4Pzp_xO7hgFCgXCnlC3aAOpheovO08a_yPPkFl34ZGA
  priority: 102
  providerName: Directory of Open Access Journals
Title Structural insights into catalytical capability for CPT11 hydrolysis and substrate specificity of a novel marine microbial carboxylesterase, E93
URI https://www.ncbi.nlm.nih.gov/pubmed/36756200
https://www.proquest.com/docview/2774894983
https://pubmed.ncbi.nlm.nih.gov/PMC9901791
https://doaj.org/article/422706ccbb3440029c67c5230942e4cd
Volume 13
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9RAEB9qRemL-G38KCv4ppHsZpPsPohoaS2CIniFewv7FXtwTerdKc1_4Z_szCZ39KT1JYRks_mY2cxvdmd-A_DKOqmDDi71ptGpDKVMFRr2tPBcBe2Fd02MtvhaHp_Iz9NiugPrckfjB1xe6dpRPamTxfztxc_-PQ74d-Rxor1FCcycRVdPCIqY4-iw3ICbaJkqKuXwZYT78c9MzlLMSuFlSQsCYjrk0VzTzR7czhFQl4Ly3y6ZrcjufxUk_Tey8pKpOroLd0aMyT4MSnEPdkJ7H24NVSf7B_Dne-SMJb4NNmuX5J0vcWfVsTiX08fZbdw_Hyi8e4a4lh18m3DOTnu_6CKJCTOtZ0v860R2W0YJmxR0RM27hhnWdr_DnJ0ZSi5kZ7NI9xR7Xdjuop9HfgY0oG_Yoc4fwuTocHJwnI6FGVInS7VKpc-aTHLZFEbIImukrjJj85KwgDLBIIjJlfGVC-gcZbbwCIOU0NYoZYPn-SPYbbs2PAHGlTXShYoycmVmuAmqaEJeWZ4HIYJLgK8_e-1G0nKqnTGv0XkhqdVRajVJrR6llsDrzTXnA2XHf1t_JGluWhLddjzQLX7U4-itJT5eVjpnbS4lLWS6snI0n66lCNL5BF6udaHG4UlrLqYN3a9lLSqi95Fa5Qk8HnRjc6u1biVQbWnN1rNsn2lnp5ECnFYzK82fXtvnM9jDt6RQuZTz57CLihVeIHxa2f047YDbT1O-H8fHXxKOGWI
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Structural+insights+into+catalytical+capability+for+CPT11+hydrolysis+and+substrate+specificity+of+a+novel+marine+microbial+carboxylesterase%2C+E93&rft.jtitle=Frontiers+in+microbiology&rft.au=Li%2C+Yang&rft.au=Rong%2C+Zhen&rft.au=Li%2C+Zhengyang&rft.au=Cui%2C+Henglin&rft.date=2023-01-11&rft.issn=1664-302X&rft.eissn=1664-302X&rft.volume=13&rft.spage=1081094&rft_id=info:doi/10.3389%2Ffmicb.2022.1081094&rft_id=info%3Apmid%2F36756200&rft.externalDocID=36756200
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1664-302X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1664-302X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1664-302X&client=summon